Question 1

What are the most cited papers from ARMGO Pharma (United States)?

Accepted Answer

The most cited paper from ARMGO Pharma (United States) is "Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl–positive human acute leukemia cells" (Ramadevi Nimmanapalli, Lianne Fuino, Corinne Stobaugh et al., 2003), with 220 citations. Next come "Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge" (177) and "Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge" (126).

Question 2

Which research topics does ARMGO Pharma (United States) publish most on?

Accepted Answer

By volume in 2022-now: Berberine and alkaloids research, Drug Solubulity and Delivery Systems, Muscle Physiology and Disorders and Advanced Drug Delivery Systems.

Question 3

Which fields of science does ARMGO Pharma (United States) work in?

Accepted Answer

In all years, 52% of research at ARMGO Pharma (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (42%), Medicine (36%), Computer Science (6%). It does 1.6× the world's share of Life Sciences.

Question 4

Is ARMGO Pharma (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 74% lower than in 2018-2021.